1. Home
  2. ARTW vs EVAX Comparison

ARTW vs EVAX Comparison

Compare ARTW & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Art's-Way Manufacturing Co. Inc.

ARTW

Art's-Way Manufacturing Co. Inc.

HOLD

Current Price

$2.20

Market Cap

12.4M

Sector

Industrials

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.84

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTW
EVAX
Founded
1956
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
31.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ARTW
EVAX
Price
$2.20
$3.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
50.1K
31.2K
Earning Date
04-08-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
233.33
N/A
EPS
0.20
N/A
Revenue
$22,975,408.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$1.20
52 Week High
$4.69
$12.15

Technical Indicators

Market Signals
Indicator
ARTW
EVAX
Relative Strength Index (RSI) 41.40 53.50
Support Level $2.12 $2.45
Resistance Level $2.49 $4.64
Average True Range (ATR) 0.17 0.37
MACD -0.01 0.08
Stochastic Oscillator 8.54 51.60

Price Performance

Historical Comparison
ARTW
EVAX

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: